A detailed history of Calamos Advisors LLC transactions in Medtronic PLC stock. As of the latest transaction made, Calamos Advisors LLC holds 535,804 shares of MDT stock, worth $45.4 Million. This represents 0.3% of its overall portfolio holdings.

Number of Shares
535,804
Previous 540,536 0.88%
Holding current value
$45.4 Million
Previous $42.5 Million 13.38%
% of portfolio
0.3%
Previous 0.27%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$76.84 - $91.03 $363,606 - $430,753
-4,732 Reduced 0.88%
535,804 $48.2 Million
Q2 2024

Jul 25, 2024

SELL
$78.71 - $87.02 $696,189 - $769,691
-8,845 Reduced 1.61%
540,536 $42.5 Million
Q1 2024

May 08, 2024

SELL
$82.84 - $88.09 $1.56 Million - $1.66 Million
-18,813 Reduced 3.31%
549,381 $47.9 Million
Q4 2023

Jan 31, 2024

SELL
$69.43 - $83.43 $3.17 Million - $3.81 Million
-45,650 Reduced 7.44%
568,194 $46.8 Million
Q3 2023

Oct 25, 2023

BUY
$78.22 - $90.4 $2.72 Million - $3.14 Million
34,785 Added 6.01%
613,844 $48.1 Million
Q2 2023

Jul 28, 2023

BUY
$79.47 - $91.38 $12.8 Million - $14.7 Million
161,384 Added 38.64%
579,059 $51 Million
Q1 2023

May 03, 2023

SELL
$76.72 - $87.58 $2.79 Million - $3.19 Million
-36,395 Reduced 8.02%
417,675 $33.7 Million
Q4 2022

Jan 25, 2023

SELL
$76.18 - $87.74 $4.41 Million - $5.08 Million
-57,879 Reduced 11.31%
454,070 $0
Q3 2022

Oct 24, 2022

BUY
$80.75 - $95.31 $18,895 - $22,302
234 Added 0.05%
511,949 $41.3 Million
Q2 2022

Aug 01, 2022

SELL
$87.4 - $113.09 $4.34 Million - $5.61 Million
-49,603 Reduced 8.84%
511,715 $45.9 Million
Q1 2022

May 03, 2022

BUY
$100.58 - $112.38 $5.07 Million - $5.66 Million
50,375 Added 9.86%
561,318 $62.3 Million
Q4 2021

Feb 01, 2022

SELL
$99.53 - $127.75 $674,614 - $865,889
-6,778 Reduced 1.31%
510,943 $52.9 Million
Q3 2021

Oct 26, 2021

BUY
$122.75 - $135.17 $6.86 Million - $7.55 Million
55,870 Added 12.1%
517,721 $64.9 Million
Q2 2021

Jul 22, 2021

BUY
$118.19 - $131.5 $8.19 Million - $9.11 Million
69,263 Added 17.64%
461,851 $57.3 Million
Q1 2021

Apr 12, 2021

BUY
$111.18 - $119.74 $664,300 - $715,446
5,975 Added 1.55%
392,588 $46.4 Million
Q4 2020

Jan 27, 2021

SELL
$100.57 - $117.14 $1.02 Million - $1.19 Million
-10,181 Reduced 2.57%
386,613 $45.3 Million
Q3 2020

Oct 26, 2020

SELL
$90.13 - $108.78 $1.89 Million - $2.28 Million
-20,975 Reduced 5.02%
396,794 $41.2 Million
Q2 2020

Jul 27, 2020

SELL
$84.11 - $103.33 $12.9 Million - $15.9 Million
-153,687 Reduced 26.89%
417,769 $38.3 Million
Q1 2020

Apr 28, 2020

SELL
$72.92 - $121.3 $18.9 Million - $31.4 Million
-258,683 Reduced 31.16%
571,456 $51.5 Million
Q4 2019

Jan 15, 2020

SELL
$104.49 - $114.54 $1.93 Million - $2.11 Million
-18,426 Reduced 2.17%
830,139 $94.2 Million
Q3 2019

Oct 21, 2019

SELL
$98.02 - $111.18 $30.4 Million - $34.5 Million
-310,256 Reduced 26.77%
848,565 $92.2 Million
Q2 2019

Aug 07, 2019

BUY
$84.15 - $99.38 $5.07 Million - $5.99 Million
60,305 Added 5.49%
1,158,821 $113 Million
Q1 2019

Apr 12, 2019

BUY
$82.45 - $93.79 $17.5 Million - $19.9 Million
212,467 Added 23.98%
1,098,516 $100 Million
Q4 2018

Jan 24, 2019

BUY
$85.8 - $99.49 $34 Million - $39.4 Million
396,320 Added 80.93%
886,049 $80.6 Million
Q3 2018

Oct 22, 2018

BUY
$85.91 - $99.17 $9.25 Million - $10.7 Million
107,727 Added 28.2%
489,729 $48.2 Million
Q2 2018

Jul 17, 2018

BUY
$77.48 - $87.83 $3.01 Million - $3.41 Million
38,849 Added 11.32%
382,002 $32.7 Million
Q1 2018

Apr 13, 2018

BUY
$76.55 - $87.26 $478,896 - $545,898
6,256 Added 1.86%
343,153 $27.5 Million
Q4 2017

Feb 13, 2018

SELL
$76.93 - $83.5 $3.44 Million - $3.73 Million
-44,721 Reduced 11.72%
336,897 $27.2 Million
Q3 2017

Oct 25, 2017

BUY
$77.71 - $84.6 $11,889 - $12,943
153 Added 0.04%
381,618 $29.7 Million
Q2 2017

Aug 09, 2017

BUY
N/A
381,465
381,465 $33.9 Million

Others Institutions Holding MDT

About Medtronic plc


  • Ticker MDT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,329,149,952
  • Market Cap $113B
  • Description
  • Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...
More about MDT
Track This Portfolio

Track Calamos Advisors LLC Portfolio

Follow Calamos Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Calamos Advisors LLC with notifications on news.